4/A: Mannatech General Counsel Amends Stock Option Vesting Schedule

Mannatech's General Counsel, Erin Kemmler Barta, filed an amended Form 4 to correct the vesting schedule for 10,000 stock options granted on June 3, 2025.

Summary

• Erin Kemmler Barta, General Counsel of Mannatech Inc. (MTEX), filed an amended Form 4 to correct a previously reported transaction.
• The amendment clarifies the vesting schedule for 10,000 stock options granted on June 3, 2025, which have an exercise price of $10.6 and expire on June 3, 2035.
• The correct vesting schedule dictates that one-third of the stock options vest on the first anniversary of the grant date, another one-third on the second anniversary, and the remaining one-third on the third anniversary.
• All granted options will vest immediately in the event of a change in control.
• Following the reported transaction, Ms. Barta beneficially owns 3,000 shares of common stock directly and a total of 19,000 derivative securities (stock options).

Sentiment

Score: 6

Explanation: The filing is neutral to slightly positive. It primarily serves as an administrative correction, which is a minor negative for oversight but quickly rectified. The underlying event is an executive stock option grant, generally viewed as a positive for aligning management incentives with shareholder interests.

Positives

• The grant of 10,000 stock options to the General Counsel aligns management incentives with long-term shareholder interests.
• The provision for immediate vesting upon a change in control offers an incentive for management during potential acquisition scenarios, which can facilitate smoother transitions.
• The company promptly corrected an administrative error, demonstrating commitment to accurate public disclosure.

Negatives

• An initial administrative error in reporting the vesting schedule required an amendment, indicating a minor oversight in the original filing process.

Future Outlook

The filing details a future vesting schedule for stock options, indicating a long-term incentive for the General Counsel. The immediate vesting upon a change in control suggests a strategic provision for potential future corporate events.

Management Comments

• "The Form 4 that was filed on 6/5/2025 was filed with the incorrect vesting schedule."
• "The correct vesting schedule is one-third of the stock options vest on the first anniversary of the date of grant, another one-third of the stock options vest on the second anniversary of the date of grant and the remaining one-third of the stock options vest on the third anniversary of the date of grant."
• "Options will vest immediately in the event of a change in control."

Industry Context

This is a routine insider transaction filing. Stock option grants with multi-year vesting schedules are common practice in corporate compensation to retain key executives and align their interests with long-term company performance. The change-in-control clause is also standard in executive compensation agreements across various industries.

Comparison to Industry Standards

• The grant of stock options to a General Counsel is a standard executive compensation practice, comparable to similar grants at companies like Herbalife Nutrition Ltd. (HLF) or USANA Health Sciences, Inc. (USNA), which also operate in the health and wellness direct selling industry.
• A three-year graded vesting schedule (one-third per year) is a common industry standard for executive equity awards, designed to promote long-term retention and performance.
• The change-in-control provision is a typical feature in executive compensation agreements, often seen in companies across various sectors to protect executive interests during M&A activities.

Corporate Governance

Stakeholder Impact

• Shareholders: Benefit from increased transparency regarding executive compensation and the alignment of management incentives with long-term company performance through stock options.
• Management: The General Counsel receives a long-term incentive, aligning her interests with the company's success.

Next Steps

• The stock options will vest according to the corrected schedule on the first, second, and third anniversaries of the grant date (June 3, 2026, 2027, and 2028).
• The options will expire on June 3, 2035, if not exercised.

Key Dates

Recommendation

This filing is an administrative amendment to correct a vesting schedule for executive stock options and does not contain information that would fundamentally alter the investment thesis for Mannatech. It is a routine disclosure of executive compensation, which is generally a neutral to slightly positive factor for long-term alignment. Therefore, a 'hold' recommendation is appropriate as there are no new material catalysts for a 'buy' or 'sell' decision based solely on this filing.

Keywords

Mannatech, MTEX, SEC Form 4/A, Insider Transaction, Stock Options, Vesting Schedule, General Counsel, Beneficial Ownership, Executive Compensation